- Geistlich Mucograft® Seal Advisory Board Meeting Report, 2013. Data on file, Geistlich Pharma AG, Wolhusen, Switzerland.
- Jung R, et al.: J. Clin Periodontol 2013; 40(1): 90-98. (clinical study)
- Thoma D, et al.: J. Clin Periodontol 2012; 39: 157-65. (clinical study)
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More